Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of levoxiracetam freeze-dried powder

A freeze-dried powder and drying technology, which is applied in the direction of freeze-drying transportation, medical preparations with non-active ingredients, medical preparations containing active ingredients, etc., can solve the problem of poor product uniformity, inconsistent properties of the upper and lower layers, and difficulty in forming a skeleton To achieve the effect of reducing adverse drug reactions, consistent properties of the upper and lower layers, and good product uniformity

Active Publication Date: 2020-09-08
CHONGQING RUNZE PHARM CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the existing levoxiracetam freeze-dried powder for injection has problems such as no fixed shape, difficulty in forming a skeleton, easy occurrence of spray bottle phenomenon in the freeze-drying process, poor product uniformity, inconsistent properties of the upper and lower layers, and the like. The problem of poor stability, before clinical use, it needs to be dissolved in 5% glucose injection or 0.9% sodium chloride injection 100 ~ 250ml, prepared as an intravenous infusion solution, levoxiracetam freeze-dried powder prepared as an intravenous infusion After the solution is injected, the insoluble particles increase with the prolongation of the storage time, which brings great safety hazards to clinical use.
In addition, the existing levoxiracetam freeze-dried powder for injection has relatively poor antibacterial properties, which may easily lead to unqualified sterility tests

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of levoxiracetam freeze-dried powder
  • A kind of preparation method of levoxiracetam freeze-dried powder
  • A kind of preparation method of levoxiracetam freeze-dried powder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] The prescription of the levoxiracetam lyophilized powder of embodiment 1 is shown in the table below:

[0016] prescription weight percentage Levoxiracetam 50％ L-serine 25％ Mannitol 14.9％ sodium glutamate 5％ sodium bisulfite 5％ phenol 0.1％

[0017] The preparation method of the levoxiracetam freeze-dried powder of embodiment 1 may further comprise the steps:

[0018] (1) Concentrated preparation: put the raw and auxiliary materials of the prescribed amount in a container, add sterilized water for injection with 10 times the weight of levoxiracetam and stir, after dissolving, add activated carbon for needles with a mass fraction of 0.1%, and stir for 30 minutes. Then filter with a 0.45 micron microporous membrane, collect the filtrate, and set aside;

[0019] (2) Dilute preparation: add sterile water for injection to the filtrate to 1000 times the volume of the filtrate, adjust the pH value to 3.2-3.6 with 0.1mol / L hydr...

Embodiment 2

[0023] The prescription of the levoxiracetam lyophilized powder of embodiment 2 is shown in the table below:

[0024] prescription weight percentage Levoxiracetam 53％ L-serine 22％ Mannitol 12％ sodium glutamate 5.7％ sodium bisulfite 7％ phenol 0.3％

[0025] The preparation method of the levoxiracetam freeze-dried powder of embodiment 2 is the same as that of embodiment 1.

Embodiment 3

[0027] The prescription of the levoxiracetam freeze-dried powder of embodiment 3 is shown in the table below:

[0028] prescription weight percentage Levoxiracetam 54％ L-serine 20％ Mannitol 10％ sodium glutamate 6％ sodium bisulfite 9.5％ phenol 0.5％

[0029] The preparation method of the levoxiracetam freeze-dried powder of embodiment 3 is the same as that of embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of L-oxiracetam freeze-dried powder. The L-oxiracetam freeze-dried powder contains the following raw materials and auxiliary materials (by weight): 50-59% of L-oxiracetam, 20-25% of L-serine, 10-17% of mannitol, 5-7% of monosodium glutamate, 5-10% of sodium bisulfate and 0.1-0.5% of phenol. The L-oxiracetam freeze-dried powder is prepared by steps of concentrated mixing, diluted mixing, freeze drying and capping. By the utilization of specific excipient combination and with the cooperation of a specific freeze-drying technology, the prepared L-oxiracetam freeze-dried powder has a fixed shape. There is no eruption phenomenon during the freeze-drying process. The product has good homogeneity, trait uniformity of upper and lower layers and strong bacterinertness, and is aseptic and qualified after examination. In addition, the product has good stability, and insoluble particles are remarkably reduced.

Description

technical field [0001] The invention belongs to the field of pharmacy, and in particular relates to a preparation method of levoxiracetam freeze-dried powder. Background technique [0002] Oxiracetam is a synthetic cyclic derivative of hydroxyaminobutyric acid (BABOB), which is only used in the central nervous system, mainly distributed in the cerebral cortex and hippocampus, and can activate, protect or promote the functional recovery of nerve cells , to improve the memory and learning function of patients with mental retardation, and the drug itself has no direct vasoactive activity, nor does it have a central excitatory effect, and the effect on learning and memory ability is a lasting promotion effect. [0003] The drug was launched in Italy in 1987, and the listed dosage forms are tablets, 800mg; capsules, 800mg; injection, 1g / 5ml. At present, only oxiracetam capsules and injections are on the market in China, and the main active ingredients used are racemates. Ye Lei...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/19A61K47/18A61K47/26A61K47/02A61K47/10A61K31/4015A61P25/00
CPCA61K9/0019A61K9/19A61K31/4015A61K47/02A61K47/10A61K47/183A61K47/26
Inventor 叶雷
Owner CHONGQING RUNZE PHARM CO LTD